Osaka, Japan

Shintaro Hirashima

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 7.7

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Takatsuki, JP (2011)
  • Osaka, JP (2013 - 2021)

Company Filing History:


Years Active: 2011-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Shintaro Hirashima: Innovator in Pharmaceutical Compounds

Introduction

Shintaro Hirashima is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrazole compounds. With a total of 3 patents to his name, Hirashima continues to push the boundaries of medicinal chemistry.

Latest Patents

Hirashima's latest patents include groundbreaking research on pyrazole compounds substituted with heteroaryl. These compounds exhibit SGLT1 inhibitory activity, making them valuable for pharmaceutical applications. His patent details a compound of Formula [X], where R is either hydrogen or halogen, and R is alkyl or halo-alkyl. Additionally, the patent describes a pharmaceutical composition comprising these compounds and their medicinal uses. Another significant patent focuses on an amide compound, providing a formula [I-W] that outlines its potential medicinal applications.

Career Highlights

Shintaro Hirashima is currently employed at Japan Tobacco Inc., where he continues to develop innovative pharmaceutical solutions. His work has garnered attention for its potential impact on drug development and therapeutic applications.

Collaborations

Hirashima collaborates with esteemed colleagues, including Hiroshi Yamanaka and Takaki Maeba. Their combined expertise enhances the research and development efforts within their field.

Conclusion

Shintaro Hirashima stands out as a prominent inventor in the pharmaceutical industry, with a focus on innovative compounds that hold promise for future medical advancements. His contributions are paving the way for new therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…